Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Passweg

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Leukemia|January 13, 2006
Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemiaS Meyer-Monard, V Parlier, J Passweg, et al.
International Journal of Laboratory Hematology|August 27, 2009
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral bloodA Rovó, G Stüssi, S Meyer-Monard, et al.
Bone Marrow Transplantation|July 25, 2007
The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictableJ-M Tiercy, G Nicoloso, J Passweg, et al.
Bone Marrow Transplantation|March 14, 2012
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow TransplantationT Ruutu, A van Biezen, B Hertenstein, et al.
Bone Marrow Transplantation|November 17, 2009
Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMTA Piccin, S McCann, G Socié, et al.
Bone Marrow Transplantation|June 20, 2025
Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortalityS Noetzlin, M Bader, A Bankova, et al.
Blood|March 26, 1999
Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working PartyJ Marsh, H Schrezenmeier, P Marin, et al.
Transplantation and Cellular Therapy|November 15, 2025
Late toxicity of allogeneic stem cell transplantation for Non-Hodgkin lymphoma patients. SBST based analysis 1997-2021 and review of literatureA von Werdt, A Künzi, A Haynes, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1998
[Establishing an umbilical cord blood bank for unrelated allogenic stem cell transplantation]A Tichelli, D Surbek, H Huxol, et al.
Annals of Internal Medicine|February 27, 1999
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working PartyA Tichelli, G Socié, M Henry-Amar, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Leukemia|January 13, 2006
Combination of broad molecular screening and cytogenetic analysis for genetic risk assignment and diagnosis in patients with acute leukemiaS Meyer-Monard, V Parlier, J Passweg, et al.
International Journal of Laboratory Hematology|August 27, 2009
Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral bloodA Rovó, G Stüssi, S Meyer-Monard, et al.
Bone Marrow Transplantation|July 25, 2007
The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictableJ-M Tiercy, G Nicoloso, J Passweg, et al.
Bone Marrow Transplantation|March 14, 2012
Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow TransplantationT Ruutu, A van Biezen, B Hertenstein, et al.
Bone Marrow Transplantation|November 17, 2009
Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMTA Piccin, S McCann, G Socié, et al.
Bone Marrow Transplantation|June 20, 2025
Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortalityS Noetzlin, M Bader, A Bankova, et al.
Blood|March 26, 1999
Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working PartyJ Marsh, H Schrezenmeier, P Marin, et al.
Transplantation and Cellular Therapy|November 15, 2025
Late toxicity of allogeneic stem cell transplantation for Non-Hodgkin lymphoma patients. SBST based analysis 1997-2021 and review of literatureA von Werdt, A Künzi, A Haynes, et al.
Schweizerische Medizinische Wochenschrift|November 24, 1998
[Establishing an umbilical cord blood bank for unrelated allogenic stem cell transplantation]A Tichelli, D Surbek, H Huxol, et al.
Annals of Internal Medicine|February 27, 1999
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working PartyA Tichelli, G Socié, M Henry-Amar, et al.
Pageof 11